A 2.7-KB PORTION OF THE 5'-FLANKING REGION OF THE MURINE GLYCOPROTEINALPHA(IIB) GENE IS TRANSCRIPTIONALLY ACTIVE IN PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS
P. Tropel et al., A 2.7-KB PORTION OF THE 5'-FLANKING REGION OF THE MURINE GLYCOPROTEINALPHA(IIB) GENE IS TRANSCRIPTIONALLY ACTIVE IN PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS, Blood, 90(8), 1997, pp. 2995-3004
The continuous generation of mature blood cells from primitive multipo
tent progenitor cells requires a highly complex series of cellular eve
nts that are still largely unknown. To examine the molecular events as
sociated with the commitment of these hematopoietic progenitor cells t
o the megakaryocytic lineage, the alpha subunit of the platelet integr
in alpha(IIb)beta(3) was used as marker. Despite an abundance of infor
mation regarding the role of this integrin in platelet adhesion and ag
gregation, the mechanisms that control the expression of the genes tha
t code for these proteins are poorly understood and the earliest hemat
opoietic cell capable of expressing them has not been clearly identifi
ed. Thus, a strategy was developed to eradicate, using a conditional t
oxigene, all the hematopoietic cells capable of expressing the alpha(I
Ib) gene in mice. This was achieved by targeting the expression of the
gene encoding the herpes simplex virus thymidine kinase (tk), specifi
cally to these cell types, using a 2.7-kb fragment of the 5'-flanking
region of the murine alpha(IIb) gene. Three transgenic lines having 1,
3, and 4 copies of the transgene, respectively were produced and anal
yzed. Administration of ganciclovir (GCV) to these mice induced a seve
re thrombocytopenia, which was due to the depletion of the entire mega
karyocytic lineage, as shown by bone marrow (BM) culture and electron
microscopy analysis. The time required to attain a severe thrombocytop
enia was dependent on the level of the expression of the transgene and
varied from 7 to 11 days. This condition was completely reversed when
GCV treatment was discontinued. Progenitor cell assays showed that th
e alpha(IIb) promoter was active in primitive hematopoietic progenitor
cells possessing myeloid, erythroid, and megakaryocytic potential and
that the transcriptional activity of the promoter decreased progressi
vely as differentiation proceeded towards the erythroid and myeloid li
neages. (C) 1997 by The American Society of Hematology.